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Introduction
Bone is the major structural and supportive tissue in the 
body, but can be compromised by degenerative diseases 
or trauma.1,2 It is understandable, therefore, that research 
into developing and optimizing the process of bone 
regeneration is intense and remains of great interest. It is 
known that such regeneration involves a complex series 
of biological events of bone induction and conduction, 
where a number of different healthy cells or tissues lend 
themselves to restore lost or damaged osseous tissues. 
This becomes a serious challenge within the field of 
regenerative medicine where there are either large or 
small quantities of missing tissue.1–3 One example of this 
is in periodontitis, which is an oral pathology that induces 
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the degradation of alveolar bone.2,4 Currently, bone 
grafting is the “gold standard” method used to tackle the 
resorption of alveolar bone;5 nevertheless, it does not 
achieve effective bone regeneration.6 Additional con-
cerns with this methodology include high cost and the 
high risks associated with a surgical procedure.7
Over the past few years, the potential of using human mes-
enchymal stem cells (hMSCs) to regenerate different tissue 
types has been highlighted due to the cells’ inherent capability 
to commit into different types of mature cells such as osteo-
blasts or chondrocytes, among others.8,9 The differentiation of 
hMSCs into bone-forming cells has also been reported, where 
three-dimensional (3D) scaffolds have been used to host the 
cells and subsequently induce and control differentiation via 
several different approaches, including tuning the matrix 
stiffness,10 incorporating growth factors,11 combining growth 
factors with low-power laser photo activation,12 heat shock 
stimuli,13 or using strontium.14 Several different types of 3D 
hydrogels have been reported in the literature, including both 
natural and synthetic systems. Examples of natural hydrogels 
include collagen, alginate, hyaluronic acid, or Matrigel.15,16 
These materials inherently contain active biomolecules and 
offer good biocompatibility, but control of their components 
(batch-to-batch variability) makes it difficult to define the 
cause of any cellular response.16 On the other hand, synthetic 
biomaterials such as poly(ethylene glycol) (PEG) and pep-
tide-based systems overcome these issues, since these materi-
als are made of well-known components providing a 
minimalistic approach to the culture of cells.17,18 Furthermore, 
the mechanical properties of synthetic gels are easily tunable 
offering an attractive route to direct the cellular response.19–21 
One limitation of these synthetic materials is that they lack 
bioactive molecules; however, these can be easily incorpo-
rated post-synthesis.16 Peptide hydrogels are highly versatile, 
their self-assembly can be controlled from the bottom-up to 
form secondary structures such as α-helixes or β-sheets, for 
example, which self-assemble to form fibrils or fibers that 
subsequently entangle to form a self-supporting structure that 
mimics the extracellular matrix (ECM).22,23 With the modular 
peptide-based systems, the solution to gel transition, the fiber, 
and gel morphology and consequently the resulting mechani-
cal properties of the 3D hydrogel can be tuned easily by pep-
tide design or varying peptide concentration, pH, ionic 
strength, and/or temperature.22,23 Moreover, such peptide 
hydrogels are inherently biocompatible and biodegradable, 
and as a consequence, they have found a wide variety of 
applications, including drug delivery, cell culture, tissue engi-
neering, biosensors, and supports for biocatalysts.18 
Furthermore, the translation of these soft materials into appli-
cations is starting to become a reality with the advent of rou-
tine procedures for peptide synthesis and purification on both 
the lab and industrial scale. This makes them easily accessi-
ble, at a reasonable cost.
Despite their numerous advantages, these peptide 
hydrogels have only been used in a few studies for the 
culture and controlled differentiation of mesenchymal 
stem cells (MSCs) for bone regeneration.24–26 One exam-
ple is from Anderson et al. where they incorporated the 
ECM moieties RGDS (arginine-glycine-aspartic acid-ser-
ine) and DGEA (aspartic acid-glycine-glutamic acid-ala-
nine) to the end of a self-assembling peptide amphiphile 
(CH3(CH2)14CONH-GTALIGQ—where G, T, A, L, I, G 
and Q are glycine, threonine, alanine, leucine, isoleucine, 
glycine, and glutamine, respectively). They used the nano-
fibrillar hydrogels to induce differentiation of hMSCs into 
osteoblasts by culturing under osteogenic stimulation. 
They went on to show that the differentiated cells were 
able to synthesize bone in vitro.24
Self-assembling peptides have also been used to cre-
ate composite materials in an attempt to control the dif-
ferentiation of hMSCs. For example, the RADA16 
peptide (AcN-RADAADARADARADA-CONH2) has 
been combined with a collagen sponge, and the hybrid 
construct induced the differentiation of hMSCs. Once the 
composite containing undifferentiated cells was trans-
ferred in vivo, alveolar bone mass was significantly 
increased, and at the same time, the population of osteo-
clasts (bone-resorbing cells) was downregulated. Authors 
hypothesized that hMSCs might have the ability to shift 
the pro-inflammatory macrophage program into an anti-
inflammatory state, which subsequently aided the forma-
tion of bone.25 The same peptide was also mixed with 
hydroxyapatite (HA), and Matsumoto et al.26 demon-
strated that this composite provided a 3D niche with good 
stiffness and osteoinductive properties that led to the 
osteogenic differentiation of murine MSCs in vivo. 
Thermal stimulation has also proved successful in the 
differentiation of stem cells, where hMSCs within the 
RADA16-I hydrogel deposited calcium and expressed 
several key bone markers only after being induced by a 
change in temperature.13
In the aforementioned approaches, generally long pep-
tide sequences that require decoration with additional 
ECM signals are needed to induce MSC differentiation. In 
this article, we present a simplified approach where we 
use a cost-effective ionic-complementary octapeptide-
based hydrogel, FEFEFKFK, where F, E, and K are phe-
nylalanine, glutamic acid, and lysine, respectively. This 
builds on our previous work where we have shown that 
this ionic-complementary peptide self-assembles into 
β-sheet-rich fibers that entangle to form a 3D self-sup-
porting matrix with controllable mechanical properties 
(Figure 1(c)).20,27,28 We have also shown that this hydrogel 
can support the culture of osteoblast cells and promote 
mineralization under osteogenic stimulation.29 Here, we 
explore the capability of the FEFEFKFK peptide hydro-
gel to support the 3D culture of hMSCs and induce the 
hMSCs’ commitment into bone-forming cells. In doing 
this, we are demonstrating its potential for bone tissue 
engineering applications.
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Experimental
Materials and reagents
FEFEFKFK peptide > 95% purity was purchased from 
Biomatik Corporation, Cambridge, ON, Canada. Primary 
hMSCs, Osteoimage™ Mineralization Assay, growth, and 
osteogenic cell culture medium were purchased from Lonza 
Walkersville Inc., Basel, Switzerland. Trypsin/ethylenedi-
aminetetraacetic acid (EDTA), DAPI-ProLong Antifade 
Reagent, Alexa Fluor 488 phalloidin, rhodamine phalloidin, 
live/dead assay, PicoGreen Assay, and human osteocalcin 
(OCN) ELISA kit were purchased from Osteocalcin ELISA: 
Life technologies, Warrington, UK. Cell culture inserts were 
purchased from ThinCert™ Greiner Bio-One Limited, 
Stonehouse, UK. The hMSCs characterization kit was pur-
chased from hMSCs characterisation kit: Merck Millipore 
Limited, Consett, UK.  Secondary antibody (sAb) anti-
mouse IgG Atto 594 and SIGMAFAST™ p-Nitrophenyl 
phosphate (p-NPP) tablets, N1891-50SET were purchased 
from Secondary Ab, SIGMAFAST p-Nitrophenyl phos-
phate, etc. Sigma-Aldrich Co. Ltd. Haverhill, UK. Rabbit 
polyclonal antibody for type I collagen (Col-I) and goat anti-
rabbit IgG Alexa Fluor 594 were purchased from Abcam, 
UK. Total collagen assay was purchased from Total Collagen 
Assay: QuickZyme Biosciences. Upper Heyford, UK.
Methods
Hydrogel preparation
FEFEFKFK peptide (>95% purity) was used to prepare a pep-
tide solution at 2.5 wt%. The peptide powder was dissolved in 
800 µL of double-distilled water (ddH2O). The peptide solu-
tion was subsequently vortexed and centrifuged (4000 r min−1), 
before placing in an oven at 90°C for 1 h to ensure complete 
dissolution. To induce gelation, 1 M NaOH (90–95 µL) and 
Dulbecco’s phosphate-buffered saline (DPBS) (100 µL) were 
added. A further vortex/centrifuge (5000 r /min−1) cycle was 
applied and the hydrogel was placed in the oven at 90°C for 
12–24 h before finally being cooled at room temperature (RT) 
to ensure formation of a homogeneous hydrogel.
Cell culture
Primary hMSCs obtained from Lonza were isolated from a 
38-year-old Caucasian male donor. Cells were grown and 
maintained following standard cell culture conditions in 
hMSCs growth medium. At 70% of confluence, cells were 
subcultured using trypsin/EDTA. Cell culture medium was 
changed every 4 days.
3D cell culture within the FEFEFKFK hydrogel
Weak hydrogels were sterilized by ultraviolet (UV) radia-
tion for 35 min before seeding the very viscous hydrogels 
with 1 × 106 cells. This was done by pipetting 200 µL of cell 
suspension containing hMSCs in growth/osteogenic 
medium on top of the weak hydrogel. The cell suspension 
was gently mixed by stirring with the pipette tip before gen-
tly pipetting up and down upon which the hydrogel 
increased in strength and yielded a homogeneous gel/cell 
suspension. A total of 300 µL of hydrogel containing 
3 × 105 cells was transferred into each 12-well cell culture 
insert. The hydrogel was left to set for 10 min at 37°C in a 
95% humidified atmosphere (20% O2) with 5% CO2. Fresh 
media changes were repeated five times at 20-min intervals 
to stabilize the pH of gels to physiological pH. After 24 h, a 
fresh media change was carried out, and subsequent media 
changes were undertaken every 4 days to aid cell growth 
within the hydrogel. For all stimulated samples, cells were 
treated with osteogenic media after 2 days of culture.
Cell viability
Cell viability was explored using a standard live/dead 
assay. Live/dead assay solution was prepared using 1.5 mL 
of phosphate-buffered saline (PBS) containing 2.5 µL of 
4-µM ethidium homodimer-1 (EthD-1) assay solution and 
1.5 µL of 2-µM calcein acetoxymethyl (AM) assay solu-
tion. The assay solution was pipetted on top of each hydro-
gel and then incubated under standard cell culture 
conditions for 20 min. The assay solution was then 
removed and samples were viewed under a Leica TCS SP5 
Figure 1. Schematic representation of the FEFEFKFK peptide self-assembly where hydrophobic phenylalanine (F), hydrophilic and 
negatively charged glutamic acid (E), and hydrophilic and positively charged lysine (K) are red, orange, and blue, respectively: (a) as 
building blocks, (b) as amino acids in the octapeptide associating via electrostatic interactions to form β-sheet secondary structures, 
and (c) form elongated fibers through non-covalent interactions, which in turn are capable of entangling into a nano-fibrous 
network.
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confocal microscope. To determine the number of viable 
cells, five different confocal microphotographs (represent-
ing five different areas of hydrogel) were used to manually 
quantify viable cells. Cell clusters were considered as a 
single cell.
Cell proliferation
The hMSC proliferation was quantified using PicoGreen 
dsDNA Assay. Gels were rinsed twice using DPBS and 
then they were resuspended in 700 µL of cold lysis buffer 
(200-mM Tris-HCl, 20-mM EDTA/ddH2O/1% Triton 
X-100) for 15 min. To ensure complete cell lysis, samples 
were vortexed vigorously and subjected to three freeze–
thaw cycles. Thereafter, samples were resuspended, and 
100 µL of gel/cell suspension was plated into dark 96 
wells, where 100 µL of a working solution of Quant-iT 
PicoGreen reagent was added. The samples were incu-
bated for 2–5 min at RT. Fluorescence readings were 
obtained in a plate reader (FLUOstar OPTIMA BMG 
LABTECH) at 435 nm (excitation) and 529 nm (emission). 
A standard curve was determined using calf thymus DNA 
in serial dilutions in 1% (v/v) Triton X. A blank gel was 
used to correct the background absorbance, and the assay 
was performed in triplicate.
hMSCs characterization
Stem cell characterization was carried out using immuno-
cytochemistry (ICC). An hMSC characterization kit, from 
which Stro-1, Thy-1 (CD90), and CD19 markers, was used 
to characterize the undifferentiated state of cells either 
with or without osteogenic stimulation. After 2 days, stim-
ulated samples were treated with osteogenic media. At 
each time point, gels were rinsed twice (5 min each) with 
1× PBS. Thereafter, samples were fixed in 4% (w/v) para-
formaldehyde (PFA) for 30 min at RT. Subsequently, sam-
ples were washed three times (5 min each) with 1× PBS 
and permeabilized using Triton X-100 at 0.1% (v/v) in 
DPBS for 15 min at RT. Samples were then blocked with 
1% (v/v) bovine serum albumin (BSA) for at least 2 h at 
RT and incubated overnight at 4°C with mouse primary 
antibodies (pAb) anti-STRO-1, anti-THY-1 (CD90), and 
anti-CD19, respectively, at the ratio stipulated by the man-
ufacturer (1:500 dilution). The next day, samples were 
washed twice (5 min each) with 1× PBS and twice with 
blocking solution. After the last wash, samples were left in 
the blocking solution for at least 30 min. Thereafter, sam-
ples were incubated for 2 h at RT in the dark with a sAb 
anti-mouse IgG Atto 594, along with Alexa Fluor 488 
phalloidin to target F-actin filaments. Both sAb and phal-
loidin were used at ratios stipulated by the manufacturer 
(1:250). Samples were finally washed three times (5 min 
each) with 1× PBS before being mounted on glass slides 
using DAPI-ProLong Antifade Reagent to stain cell nuclei. 
Images were obtained using a Leica TCS SP5 confocal 
microscope. Two independent assays were performed, 
each in duplicate.
ICC for Col-1
Type 1 collagen production within the gel sample was 
examined visually using the same ICC staining procedure 
as for hMSCs characterization, except here a rabbit poly-
clonal antibody for Col-1 was used as the stain at a ratio 
stipulated by the manufacturer (1:250). After 24 h, samples 
were incubated for 2 h at RT in the dark with a goat anti-
rabbit IgG Alexa Fluor 594 along with Alexa Fluor 488 
phalloidin to target F-actin filaments. Both sAb and phal-
loidin were used at ratios stipulated by the manufacturer 
(1:250). The samples were mounted and confocal images 
obtained as before. Two independent assays were again 
performed in duplicate.
Quantification of proteins
The production of bone proteins by hMSCs was quantified 
using spectrophotometric assays. After 6 and 12 days of 
culture, cell-loaded gels were subjected to three freeze–
thaw cycles to ensure cellular lysis. The osteogenic mark-
ers that were quantified included total collagen, OCN, and 
alkaline phosphatase (ALP). For all protein quantification 
experiments, cells without osteogenic stimulation were 
used as control, and a blank gel was used to correct for 
background absorbance. All experiments were normalized 
to cell numbers from the PicoGreen Assay and gel volume 
over time. Details for each assay are given below.
Total collagen
Total collagen production was determined using a total 
collagen assay. After resuspending and lysing, samples 
were vortexed and hydrolyzed over 20 h at 95°C with 100-
µL 12 M HCl. Samples were subsequently diluted 1:1 in 
4 M HCl, pipetted into a 96-well plate, before adding 75 µL 
of an assay buffer and leaving to incubate for 20 min at RT. 
Afterward, 75 µL of a detection reagent was added, and the 
sample transferred into the oven (60°C) for 1 h. Absorbance 
measurements were obtained at 570 nm, using a plate 
reader (TECAN Infinite M200). Two independent assays 
were undertaken in triplicate.
OCN
OCN expression was determined using a Human OCN 
ELISA Kit. After cellular lysis using cold distilled water, 
samples were vortexed and pipetted into a 96-well plate. 
Subsequently, a working anti-OST-HRP solution (100 µL) 
was added to each well, the plate covered and incubated 
for 2 h at RT. Each well was then rinsed three times with a 
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washing solution before adding 100 µL of a chromogen 
solution (tetramethylbenzidine) and incubating for 30 min 
at RT in the dark. The reaction was stopped by adding 
100 µL of a stop solution (1 N HCl). Absorbance measure-
ments were obtained within 1 h at 450 nm using a plate 
reader (TECAN Infinite M200). Two independent assays 
were performed in triplicate.
ALP
ALP activity was monitored using a colorimetric ALP and 
peroxidase substrate detection system. The cell lysate (20 µL) 
was added to transparent 96-well plates together with 200 µL 
of p-NPP solution (1 mg mL−1 p-NPP, 0.2-M Tris buffer in 
5-mL ddH2O) SIGMAFAST p-NPP tablets, N1891-50SET. 
The reaction was stopped with 3 M NaOH. The absorbance 
of samples was measured using a plate reader (LabSystems 
Multiskan Ascent) at 405 nm every 30 s for 30 min. Two 
independent assays were performed in triplicate.
Mineralization (HA deposition)
The extent of mineralization was determined using an 
Osteoimage Mineralization Assay. After each culture time 
point, the gels were washed with 1× PBS before being fixed 
with 4% (w/v) PFA for 20 min at RT. Samples were subse-
quently washed further twice (5–10 min each) with 
Osteoimage wash buffer and then incubated with 1.5-mL 
staining reagent, along with rhodamine phalloidin (1:250 
dilution) to target F-actin filaments at RT in the dark for 
30 min. After incubation, gels were washed three times 
(5 min each) with wash buffer before mounting the samples 
on glass slides using a DAPI-ProLong Antifade Reagent to 
stain the cell nucleus. Images were obtained using a Leica 
TCS SP5 confocal microscope. To quantify the extent of 
mineralization, washed samples were resuspended in 700-
µL wash buffer and their fluorescence determined in a fluo-
rescent plate reader at a 492/520 nm ratio. Two independent 
assays were performed, again in triplicate.
Hydrogel volume tracking
The percentage volume of FEFEFKFK peptide hydrogel 
(25 mg mL−1, 20 mM) with and without cells was qualita-
tively and quantitatively monitored over time under cell 
culture conditions. Photographs of hydrogels were taken 
using a Canon EOS 1100D camera. To quantify the per-
centage of hydrogel volume, 300 µL of hydrogel was 
plated into each cell culture insert and this gel was consid-
ered as 100% hydrogel volume. At days 1, 6, and 12, the 
cell culture medium was removed completely from each 
hydrogel. Thereafter, 700 µL of distilled water was added 
to each hydrogel, which was broken down by pipetting up 
and down. The resuspended solution was transferred into a 
15-mL Falcon tube, and the total volume was measured 
using a standard micropipette. Finally, the difference in 
volume obtained from each sample was subtracted from 
the 100% gel volume. Two independent measurements 
were carried out in duplicate.
Oscillatory rheology
The viscoelastic properties of the hydrogel (25 mg mL−1, 
20 mM) were undertaken using an AR-G2 rheometer 
equipped with a 20-mm parallel plate. Hydrogels with and 
without cells were run in parallel. A total of 150 µL of hydro-
gel sample was loaded onto the bottom plate, and the upper 
plate was lowered until it reached a 250 µm gap. Thereafter, 
the sample was left for 10 min to equilibrate before record-
ing the elastic (G′) and viscous (G″) moduli as function of 
strain (0.04%–40.00%) at 1 Hz and oscillatory frequency 
(0.01–15 Hz) at 0.2% strain. Samples were maintained at 
physiological temperature (37°C) using a Peltier stage, and 
a solvent trap was used to minimize sample dehydration. All 
measurements were carried out in triplicate.
Hydrogel proteolytic degradability
FEFEFKFK peptide hydrogel (25 mg mL−1, 20 mM) was 
incubated with and without hMSCs using cell culture 
media, both in the presence and absence of 10% fetal 
bovine serum (FBS) following the procedures outlined 
earlier. After incubation for 1, 6, and 12 days, the gel was 
broken down by dilution to 1 mg mL−1 in 1% trifluoro-
acetic acid (TFA) in water/acetonitrile (50/50 v/v). The 
peptide solutions were injected on the reversed-phase 
high-performance liquid chromatography (RP-HPLC) col-
umn Phenomenex Jupiter 4-µm Proteo column 90 Å 
(250 × 4.66 mm). An elution gradient was used with a flow 
rate of 1 mL min−1 that went from 90% solvent A (0.05% 
TFA in H2O)/10% solvent B (0.05% TFA in CH3CN) to 
30% solvent A/70% solvent B in 45 min. The peptide sta-
bility was expressed as a percentage of intact FEFEFKFK 











where, AUC t and t0 are the area under the HPLC curve 
from the FEFEFKFK peptide peak as calculated by 
Chromeleon software at the sampling time point and day 
0, respectively. At least two repeat experiments were 
undertaken.
Statistical analysis
Statistical significance in PicoGreen, total collagen, 
ALP activity, OCN quantification assays, hydrogel vol-
ume, mechanical properties, and proteolysis was deter-
mined using one-way analysis of variance (ANOVA) 
followed by post-hoc comparisons (Tukey’s method).
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Results and discussion
Cell viability, morphology, and proliferation
The first step in this work was to confirm the capability of 
the FEFEFKFK peptide hydrogel to support the viability 
and proliferation of hMSCs when incorporated within the 
peptide hydrogel in 3D. Cell viability was therefore 
assessed initially using a live/dead assay over a period of 
12 days of culture. It is clear from the confocal images 
shown in Figure 2 that the majority of hMSCs remained 
viable over 12 days of culture within the gel, with only a 
few dead cells being present. Therefore, the gel provided 
an adequate niche for cell survival. Cell viability was sub-
sequently quantified (Figure 3), and it was found that the 
number of living cells increased significantly during the 
first 6 days and then decreased slightly over the remaining 
days of culture. This decrease could be due to cells under-
going cell senescence or death. The number of dead cells 
in Figure 2 does not increase over time in culture and as 
will be shown later, the cells remain functional and posi-
tive effects on the markers studied were observed, so 
senescence is not likely. Such viability data are consistent 
with what we have previously reported for human osteo-
blasts29 and bovine chondrocytes19 when encapsulated 
throughout the FEFEFKFK hydrogel. This is also in agree-
ment with the results reported using other synthetic scaf-
folds, which include peptide- and polymer-based hydrogels 
such as RADA and PEG gels, where rat neural stem cells 
and hMSCs showed a steady viability within such gels at 
similar cell culture time.13,30
Confocal microscopy imaging (Figure 2) also shows 
that most cells acquired a round/ovoid morphology during 
the first day of culture. As time progressed further (days 6 
and 12), cells acquired a definite round shape. This was 
expected, as cells typically remain rounded when embed-
ded within a 3D niche that contains no adhesion sites. 
Optical microscopy was also used to confirm cell morphol-
ogy (Figure 4(a)) and the data obtained corroborated the 
conclusions from confocal imaging. Interestingly, hMSCs 
were also cultured in 2D on top of the tissue culture plastic 
(TCP) where they acquired a typical spindle morphology 
and these became wider under osteogenic stimulation 
(Figure 4(b)), as is typical for flattened surfaces.9
The extent of cell proliferation within the FEFEFKFK 
hydrogels with no stimulation was subsequently quantified 
using the PicoGreen Assay and the results are given in 
Figure 5. It is clear that cell numbers were sustained, indi-
cating that cells could be maintained within the hydrogel 
over 12 days of culture. There was a slight drop in number 
between days 6 and 12, which matches with the viability 
trend at the same time point. Moving through these time 
points, the rate of overall cell proliferation is likely to be 
sufficient to lead to bone formation, if and when osteo-
genic differentiation is induced within the gel. This is 
because it is known that the rate of human osteoblast popu-
lation in native bone is relatively lower and ~60%–90% of 
the osteoblast population dies by apoptosis after synthesiz-
ing new osteoid.31 Such osteoblast proliferative behavior 
Figure 2. Live/dead assay showing viable (green) and non-viable (red) hMSCs within the FEFEFKFK gel over 12 days of cell culture. 
Magnification = 20×. Scale bars = 250 µm.
Figure 3. Quantification of viable cells encapsulated within 
the FEFEFKFK gel over 12 days of culture by manually counting 
viable cells in five different confocal microphotographs (n = 3).
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observed here is commensurate with similar systems in the 
literature.32,33
MSCs characterization
To demonstrate that the hMSCs seeded into the peptide 
hydrogels were fully undifferentiated initially and 
remained so over time, the plasticity of the cells within the 
hydrogels was determined using ICC staining for two 
well-known positive hMSCs markers; stro-1 and CD90 
(thy-1), as well as staining for CD19 as the negative con-
trol. This was done for cells embedded within the hydro-
gel, both with and without osteogenic stimulation, and all 
images obtained were compared to the non-sAb controls to 
rule out the staining observed being due to non-specific 
staining. Confocal images shown in Figure 6(a) and (b) 
revealed the presence of both Stro-1 and Thy-1, respec-
tively, over 12 days of culture in growth medium only, that 
is, non-stimulated conditions. This confirmed the stem cell 
characteristic of cells within the gel. Interestingly, the 
expression of the positive stem cell markers decreased 
slightly at day 12. This stem cell marker behavior has been 
reported in the literature, where subcultured stem cells 
tend to lose the expression of their stemness markers over 
time, either with or without osteogenic stimuli.34,35 
Likewise, the loss of the expression of Thy-1 in hMSCs 
cultured under chondrogenic stimuli has been reported 
using different substrates including alginate gels.36 When 
stem cells within FEFEFKFK hydrogels were stimulated 
to differentiate using osteogenic media, the positive “stem 
cell” markers were found to be expressed at a much 
reduced level in comparison to observed cells cultured 
with growth media, a result that matches with other stud-
ies reported in the literature.34,35 In support of the charac-
terization of the hMSCs, there was no evidence of the 
presence of the negative control CD19 within the hydro-
gel (Figure 7) both with and without osteogenic stimula-
tion. This was expected, as it is a marker exclusively 
expressed by B lymphocytes. In summary, these findings 
suggest that stem cells may shift from their undifferenti-
ated state into a differentiated state in the presence of the 
osteogenic medium.
ECM production
To confirm the possible differentiation of hMSCs within 
the hydrogel matrix, the expression of Col-1 was moni-
tored over time in culture by staining for the prototypical 
Figure 4. Optical microscopy images showing the morphology of hMSCs when (a) encapsulated within the FEFEFKFK hydrogels 
and (b) placed on TCP, with and without osteogenic induction over 12 days of culture. Magnification = 10×. Scale bar = 100 µm.
Figure 5. DNA content normalized to hydrogel volume over 
12 days of culture (n = 3) under non-stimulated conditions.
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marker using ICC. The expression of Col-1 is a good 
parameter of cell differentiation in this case, as it is the 
major component of organic bone matrix (~90%).1 As a 
first step, samples were imaged in the absence of the Col-1 
antibody, and images taken did not exhibit any fluorescent 
signal, thus confirming the hydrogel and cells did not dis-
play any unspecific or auto-fluorescence. Confocal imag-
ing of samples with the Col-1 antibody revealed hints of 
Col-1 inside the hydrogel at days 6 and 12 under non-stim-
ulating conditions as evidenced by the red staining (Figure 
8). Under osteogenic stimulating conditions, some Col-1 
staining was also observed at day 6 of culture; however, 
this increased significantly at 12 days of culture suggesting 
the cells committed into an increasing differentiated pro-
file over extended time in culture but not necessarily 
toward an osteoblastic lineage. Furthermore, it is clear 
from the confocal images in Figure 8 that the stimulated 
cells embedded within the FEFEFKFK matrix were also 
able to deposit the synthesized collagen in the surrounding 
gel, not just close to the cells. This behavior is also remi-
niscent of our previous work where human osteoblasts 
were cultured in 3D within the same hydrogel.29 The total 
collagen synthesized by stem cells was subsequently quan-
tified using a spectrophotometric assay. The normalized 
total collagen production observed during these assays is 
shown in Figure 9(a) for both the non-stimulated and oste-
ogenically stimulated cells. The data corroborate the trends 
observed in the ICC staining experiments, where collagen 
was produced in the stimulated conditions and the quantity 
of collagen increased over prolonged time in culture. This 
pattern in collagen synthesis is in good agreement with 
data reported for the differentiation of MSCs into osteo-
blast cells in other matrices such as PEG30 and honeycomb 
collagen scaffold.37
The production of Col-1 is, however, not exclusive to 
osteoblast cells, therefore, we also quantified the production 
and activity of two key bone proteins involved in bone for-
mation and mineralization: OCN and ALP. Data normalized 
Figure 6. (a) ICC staining for Stro-1 (red) and (b) Thy-1 (red) within the FEFEFKFK hydrogel, with and without osteogenic stimuli 
over 12 days of culture (n = 2). Cell nuclei and F-actin are stained in blue and green, respectively, to characterize cell architecture. 
Magnification = 40×. Scale bar = 100 µm.
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Figure 7. ICC staining for CD19 (red) within the FEFEFKFK 
gel with and without osteogenic stimuli over 12 days of 
culture (n = 2). Cell nuclei and F-actin are stained in blue 
and green, respectively, to determine the cell architecture. 
Magnification = 40×. Scale bars = 100 µm.
Figure 8. ICC staining for type I collagen (red) within the 
FEFEFKFK gel with and without osteogenic stimuli over 12 days 
of culture (n = 2). Cell nuclei and F-actin are stained in blue 
and green, respectively, to determine the cell architecture. 
Magnification = 20×. Scale bars = 250 µm.
Figure 9. Quantification of bone protein production 
by hMSCs: (a) total collagen production, (b) osteocalcin 
production, and (c) alkaline phosphatase activity, with and 
without osteogenic stimuli within the hydrogel over 12 days 
of culture. Data are reported as mean ± standard deviation for 
n = 2 and are normalized against cell numbers and hydrogel 
volume.
to cell numbers and hydrogel volume over time for each of 
these are given in Figure 9(b)and (c), respectively. It is clear 
that the data for the presence of OCN are very similar to the 
production of collagen (Figure 9(a)), where the production 
of OCN was observed at the latest time point for the osteo-
genic stimulated sample. This is in good agreement with 
similar studies reported in the literature24,37 and points to 
osteogenic differentiation of the hMSCs. Similar trends 
were observed for ALP activity (Figure 9(c)), although there 
was less of an increase between the non-stimulated and 
stimulated cells in this case. In the literature, the majority of 
studies report an increase in the presence of ALP once the 
osteogenic differentiation of hMSCs is induced.13,38 It is 
known that the differentiation of hMSCs into osteoblasts in 
vitro can take between ~14 and 30 days, where cells gener-
ally proliferate during the first 7 to 14 days. Only at this 
point the differentiation process starts where the transcrip-
tion and the expression of ALP are carried out.13,39 Therefore, 
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in this study, we believe the differentiation of hMSCs and 
subsequent expression of ALP could have been accelerated 
and reached its peak over the first 12 days. This has been 
reported by others13,38 and could explain the lack of signifi-
cant increase in ALP activity between days 6 and 12 under 
osteogenic stimulation within the hydrogel. Based on these 
studies, any cell differentiation observed during culture 
could be concluded to be induced either by the environment 
surrounding cells (i.e. the hydrogel) or the osteogenic stimu-
lation applied (i.e. presence of the osteogenic media), or 
both. Certainly, further studies are needed to determine 
whether the mechanical properties of gel or the 3D environ-
ment induced this acceleration of the ALP production rate.
Thus far, we have shown that the FEFEFKFK peptide 
hydrogel can act as a 3D support for the proliferation and 
differentiation of hMSCs into osteoblast cells that go on to 
produce key bone proteins involved in bone formation. 
This is greatly facilitated when the cells are stimulated by 
osteogenic media. The next step was to determine whether 
these hydrogels support mineralization under the same cell 
culture conditions. First, to rule out that the mineralization 
occurred via cell death/apoptosis inducing mechanism, we 
looked at the number of live/dead cells and did not see a 
significant number of dead cells present. Second, we mon-
itored mineralization by introducing a staining reagent into 
the hydrogel that specifically binds to HA. Any binding 
was then detected using a fluorescent assay and compared 
to the control sample, which remained completely blank, 
where no cells were incorporated within the gel.
Confocal images of stained samples at days 6 and 12 of 
culture, both with and without the addition of osteogenic 
stimuli, are given in Figure 10(a). The presence of HA 
(green fluorescence staining) was apparent after 6 days of 
culture with osteogenic stimulation. Our findings correlate 
with those reported in the literature, where hMSCs differ-
entiated under osteogenic stimulation and subsequently 
mineralized within polyethylene glycol diacrylate 
(PEGDA) hydrogels that were functionalized with the 
short fibronectin peptide RGD.40,41 Although the process 
of bone mineralization is not fully understood yet, it is 
believed that apatite binds to Col-1 fibrils, which serve as 
a spatial framework for crystal deposition.42 Non-collagen 
proteins including OCN are needed to complete this pro-
cess.43,44 Thus, we believe that HA deposits observed 
within the gel derived from the interaction of amorphous 
calcium phosphate with the bone proteins deposited by dif-
ferentiated cells in the fibrillar network of the peptide 
hydrogel. Only a faint hint of green fluorescence is 
observed after 12 days of culture without the addition of 
osteogenic stimulation, which may be explained due to the 
lower or null production of bone proteins observed in the 
protein quantification. The amount of mineralization 
occurring in each case was also quantified, and it is clear 
from the data in Figure 10(b) that significant mineraliza-
tion only occurred after prolonged time in culture under 
stimulated conditions. Such behavior agrees well with the 
previous protein quantification work presented in Figure 9 
indicating bone ECM production. This finding clearly 
demonstrates the suitability of the FEFEFKFK hydrogel to 
host hMSCs and promote their differentiation into osteo-
blast cells, in particular, under osteogenic stimuli. In addi-
tion, this finding is in good agreement with previous 
studies, where the osteogenic differentiation of murine and 
human stem cells has been induced in the longer RADA16 
peptide sequence45 and in a phosphate-containing PEG46 
gel, respectively, over a similar time period of 1–4 weeks 
of culture. The advantage of our octapeptide-based system 
is its short length (hence, reduced cost), it does not require 
the addition of ECM-functionalized peptide groups (such 
Figure 10. (a) Confocal imaging of mineralization/
hydroxyapatite deposits (green) within the FEFEFKFK 
hydrogel, with and without osteogenic stimuli over 12 days 
of culture (n = 2). Cell nuclei and F-actin are stained in blue 
and red, respectively. Magnification = 40×. Scale bars = 100 µm. 
(b) Quantification of relative fluorescence units normalized 
to cell numbers from the PicoGreen Assay to determine 
mineralization within the hydrogel with and without osteogenic 
stimuli over 12 days of culture (n = 2).
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as RGDS and DGEA), and also its ease of handling and 
injectability.
Hydrogel behavior
The 3D fibrillar network structure of the peptide hydrogels 
offers a protective matrix for cells, and when encapsulated, 
the cells can mirror the physiological functions undertaken 
in the body such as proliferation or ECM remodeling.47,48 
As hydrogels typically degrade progressively, they fuse 
with native tissues without the need to introduce additional 
hydrolytic elements. Herein, it is hypothesized that the 
physiological cell activity described earlier (proliferation, 
ECM remodeling, and mineralization) might influence the 
mechanics, and hence the inherent biodegradability of the 
hydrogels is studied here. In turn, we believe that the bio-
degradability of hydrogels may influence cellular func-
tion. Consequently, the volume and viscoelastic properties 
of the hydrogel were monitored as a function of time in 
both the presence and absence of cells. Over the course of 
12 days of cell culture conditions, the FEFEFKFK peptide 
hydrogels (25 mg mL−1, 20 mM) shrank progressively 
(Figure 11(a)). This was expected due to the hydrolytic 
effect as the surrounding media was changed continuously. 
In addition, enzymes present in the serum along with the 
natural proteolytic activity from the ECM remodeling by 
the cells could contribute to hydrogel shrinkage.49,50 
Interestingly, samples containing cells exhibited a more 
noticeable decrease in volume in comparison with control 
samples with no cells. This is most evident at day 12 of 
culture (Figure 11(a)). To monitor this further, the percent-
age of hydrogel volume was quantified and results are pre-
sented in Figure 11(b). It was found that both hydrogel 
samples decreased progressively, and a lower hydrogel 
volume was recovered over culture time in the presence of 
cells. This corroborates the visual observations and also 
highlights the erosion and/or biodegradability of the 
FEFEFKFK hydrogel. Such hydrogel erosion might initi-
ate intracellular signaling that would lead to cell migration 
or downregulation of cellular activity, as the cells sense a 
smaller area in which they interact and survive in vitro. It 
should be noted that this is not necessarily occurring when 
cell-loaded hydrogels are transferred into the body.51,52
Thus far, our results suggest erosion of the hydrogels 
due to media changes but also an effect of enzyme-medi-
ated activity from cells and/or serum on the biodegrada-
bility of the peptide hydrogel. Interestingly, El-Fiqi et al., 
reported the progressive shrinkage of collagen hydrogels 
and the subsequent decrease in the viscoelastic properties 
of such hydrogels when MSCs were cultured in 3D. They 
also showed that the incorporation of mesoporous bioac-
tive glass nanoparticles (mBGns) into their hydrogels 
improved the mechanical properties and decreased the 
shrinkage of collagen hydrogels caused by the proteolytic 
effect derived from cells and serum.50 To study whether 
the viscoelastic properties of the FEFEFKFK hydrogels 
studied here were influenced by any cellular metabolic 
activity, the elastic behavior of the hydrogels with and 
without cells was monitored as a function of time in cul-
ture. The hydrogels containing cells displayed a progres-
sive decrease in the storage modulus, G′, which decreased 
from 45,000 ± 6000 Pa at day 1 to 10 ± 1 Pa at day 12 (Figure 
12). The control samples exhibited a similar trend, although 
G′ decreased to a lesser extent from 40,000 ± 7000 Pa at day 
1 to 4500 ± 1000 Pa at day 12 (Figure 12). These data match 
the trends observed in the hydrogel volume studies and cor-
roborate the proposal that there is a proteolytic effect on 
the hydrogel degradability derived either from cells or 
serum, or both. Likewise, these findings are in good 
agreement with our observations relating to ECM remod-
eling by the hMSCs within gels discussed earlier and with 
other similar studies in the literature.50,53 For example, 
Swanekamp et al. recently demonstrated that the G′ of 
such peptide hydrogels decreased significantly when the 
hydrogels were subjected to the enzymatic activity of var-
ious proteases, including α-chymotrypsin, trypsin, and 
proteinase K.
In parallel, the mechanical properties of the surround-
ing ECM may have a significant influence on cell func-
tions including proliferation54,55 and differentiation even in 
Figure 11. (a) Photographs of FEFEFKFK hydrogels over 
12 days of cell culture conditions. (b) Measurement of the 
percentage of FEFEFKFK hydrogels volume, with and without 
cells over 2 weeks in cell culture conditions. Data are reported 
as mean ± standard deviation for n = 3.
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the absence of any osteogenic stimuli.17,54–56 For example, 
hydrogel stiffness might impact cell numbers, as it has 
been reported that relatively stiff hydrogels with G of 
20,000 Pa can induce the osteogenic differentiation of 
MSCs even without the use of any osteogenic supple-
ments.17 Once differentiated, the rate of hMSC prolifera-
tion might decrease as reported by Anderson et al.24 The 
initial elastic modulus (ca. 40,000 Pa) recorded for 
FEFEFKFK hydrogel (20 mM) is higher in comparison 
with other peptide hydrogel systems used for differentiat-
ing stem cells, such as RADA-16.57,58 The osteogenic 
commitment of hMSCs might potentially, therefore, be 
induced only by the gel stiffness here, which might explain 
the observed hints of ECM production without osteogenic 
stimuli. At this stage, we do not rule out that both the oste-
ogenic stimulation and the mechanical properties of the gel 
might impact the plasticity of hMSCs and this hypothesis 
is the subject of an ongoing study.
Overall, the findings discussed suggest that the 
FEFEFKFK peptide hydrogel has a substantial effect on the 
hMSCs viability, proliferation, differentiation, and ECM 
production. In parallel, hMSCs can modulate their sur-
rounding hydrogel. When the hMSCs start the production 
of ECM, they secrete matrix-altering proteins including 
extracellular proteases such as plasmin and matrix metal-
loproteinases (MMPs).59–61 The secreted proteases could 
have a proteolytic effect on the hydrogel biodegradability. 
To look into this in further detail, hMSCs were cultured in 
a 25 mg mL−1 gel (20 mM) and incubated for 12 days, before 
the gel was disassembled by dilution in 1% TFA in water/
acetonitrile (50/50 V/V), and the quantity of octapeptide 
present was determined using RP-HPLC. The TFA was 
used to ensure the denaturation of cell and serum proteases 
to stop any hydrolytic reactions at the desired time points. 
After 1 day of culture of hMSCs with serum, the hydrogel 
lost a significant quantity of hydrogel with only 
38.3% ± 4.4% intact octapeptide remaining (Figure 12). 
The hydrogel was further degraded and/or eroded over 
time, with ~90% degraded after 6 days (9.1% ± 0.1% intact 
peptide) and almost completely degraded after 12 days, 
with only 1.2% ± 0.9% intact octapeptide remaining. To 
explore whether the observed loss of peptide hydrogel was 
catalyzed by proteases secreted by cells, hMSCs were cul-
tured in the peptide hydrogel (25 mg mL−1, 20 mM) using a 
serum-free media. After 1 day, the peptide was degraded 
significantly with only 39.7% ± 9.3% octapeptide remain-
ing (Figure 12). Furthermore, hydrogel was degraded after 
incubation for longer times, with almost 80% of the octa-
peptide having degraded after 6 days (23.3% ± 0.1% intact 
peptide) and ~90% after 12 days (8.4% ± 1.4% intact pep-
tide) (Figure 12). This result clearly shows that the cells 
exhibit an inherent proteolytic activity, as they hydrolyze 
the gel most likely by secreting proteases. To evaluate the 
hydrolytic effect of serum proteases on the peptide hydro-
gel, the cell-free gel was incubated with cell culture media 
containing 10% FBS over 12 days. After 1 day incubation, 
>60% of the peptide was degraded (36% ± 0.03% intact 
peptide). Longer incubation periods showed higher hydrol-
ysis with 12.6% ± 0.2% and 5.3% ± 1.3% intact peptide 
remaining after 6 and 12 days, respectively. Swanekamp 
and co-workers have observed a similar degradability pro-
file for the pleated β-sheet peptide L-Ac-(FKFE)2-NH2 
when incubated with chymotrypsin, trypsin, and proteinase 
K over 5 days. The 0.5-mM peptide solution showed sig-
nificant degradability with the three proteases with ~50% 
loss after 1 day and >95% hydrolysis after 5 days of incuba-
tion. Also, they observed that the 8-mM peptide hydrogel 
integrity was almost totally impaired after >4 h of incuba-
tion with 1 mg mL−1 chymotrypsin, indicating the break-
down of the hydrogel.53
The data presented here indicate that both serum and 
cells induce substantial hydrolytic breakdown of the pep-
tide hydrogel, although the majority is likely to be due to 
simple erosion during the frequent media changes as there 
is also a considerable loss of octapeptide in the hydrogel 
with no serum or cells. Having said that, the FEFEFKFK 
octapeptide is formed of natural l-α-amino acids and is 
thus inherently vulnerable to hydrolysis by proteases pre-
sent in the body. This design offers the potential use of 
such peptide hydrogels as delivery materials for cell thera-
pies, as they would protect the cells once injected in vivo 
and act as an artificial ECM support for cell proliferation 
Figure 12. (a) Elastic modulus, G′, of peptide hydrogels 
with and without cells over 12 days of cell culture conditions. 
(b) Enzyme-mediated proteolytic degradation of FEFEFKFK 
hydrogels over 12 days of cell culture conditions. Data are 
reported as mean ± standard deviation for n = 3.
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and differentiation. As the cells go onto lay down their 
own ECM, the hydrogel will degrade and be processed by 
proteases and safely excreted.
Conclusion
Results from this study demonstrate that hMSCs can be 
incorporated homogeneously and proliferate within a 3D 
ionic-complementary peptide FEFEFKFK hydrogel. These 
cells were subsequently induced to commit into osteoblast 
cells simply via the addition of osteogenic culture medium. 
This was significant as it eliminates the prerequisite of add-
ing any ECM biological cues. Once differentiated, these 
osteoblast cells were able to synthesize proteins such as Col-
1, OCN, and ALP, which are all typically involved in the for-
mation of bone. Moreover, differentiated cells supported 
within the hydrogel were able to mineralize, demonstrating 
the initial stages of bone formation. This work, therefore, 
exemplifies a simple and cost-effective biodegradable bio-
material that can be employed for the regeneration of hard 
tissues, such as alveolar bone. It requires no additional func-
tionalization with, for example, ECM-isolated ligand 
sequences. Furthermore, it does not require any complex 
synthesis step, which is associated with arginine-rich pep-
tides such as the RADA systems. This octapeptide system 
has the added potential of being a biodegradable injectable 
viscoelastic material in vivo or in situ, avoiding most of the 
post-surgical complications currently employed during bone 
grafting today.
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